Skip to main content
SpringerLink
Log in

Prognostic Factors in Non-Small Cell Lung Cancer

  • Chapter
Malignant Tumors of the Lung

Abstract

The TNM staging classification is the strongest determinate of outcome in patients with non-small cell lung cancer (NSCLC); as a result, it is used to guide treatment decisions (see Chap. 16). Only those patients who undergo complete resection or are treated aggressively with combined modality therapy have the potential for long-term survival. However, even with stage IA tumors, the 5-year survival rate after resection is only 67% (Mountain 1997; Kwiatkowski et al. 1998), indicating that a significant proportion of patients with resectable disease have virulent tumors. The range of survival potentials within each stage underscores the heterogeneous nature of the disease. This has led to the study of other prognostic variables that might complement stage, and to a search for tissue-based, as well as noninvasive, methods for better predicting prognosis and guiding treatment choice (Pugsley et al. 2002; Sorensen 1994).By refining the prognostic assessment of a given patient within (or potentially across) stage subgroups, a better tailored therapy might be feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahuja V, Coleman RE, Herndon J et al (1998) The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 83:918

    Article  PubMed  CAS  Google Scholar 

  • Aisner J, Hansen HH (1981) Commentary: current status if chemotherapy for NSCLC. Cancer Treat Rep 65: 979

    PubMed  CAS  Google Scholar 

  • Alama A, Constantini M, Repetto L et al (1990) Thymidine labeling index as prognostic factor in resected non-small cell lung cancer. Eur J Cancer 26:622

    Article  PubMed  CAS  Google Scholar 

  • Albain KS, Crowley JJ, LeBlanc M et al (1991) Survival determinants in extensive stage non-small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 9:1618

    PubMed  CAS  Google Scholar 

  • Al-Kattan K, Sepsas E, Townsend E et al (1996) Factors affecting long-term survival following resection for lung cancer. Thorax 51:1266

    Article  PubMed  CAS  Google Scholar 

  • Andre F, Grunenwald D, Pignon JP et al (2000) Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18:2981

    PubMed  CAS  Google Scholar 

  • Apolinario RM, van der Valk P, de Jong JS et al (1997) Prognostic value of the expression of p53, bcl-2 and bax oncoproteins and neovascularization in patients with radically resected nonsmall cell lung cancer. J Clin Oncol 15:2456

    PubMed  CAS  Google Scholar 

  • Battifora H, Sorensen HR, Mehta P et al (1992) Tumor-associated antigen 43-9F is of prognostic value in squamous cell carcinoma of the lung. Cancer 70:1867

    Article  PubMed  CAS  Google Scholar 

  • Berendsen HH, de Leij L, Poppema S et al (1989) Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 7:1614

    PubMed  CAS  Google Scholar 

  • Bernet F, Brodbeck R, Guenin MO et al (2000) Age does not influence early and late tumor-related outcome for bronchogenic carcinoma. Ann Thorac Surg 69:913

    Article  PubMed  CAS  Google Scholar 

  • Blackstock AW, Herndon JE 2nd, Paskett ED et al (2002) 0utcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. J Natl Cancer Inst 94:284

    Article  PubMed  Google Scholar 

  • Bonomi P (2002) Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol 29 [Suppl 4]:78

    Article  PubMed  CAS  Google Scholar 

  • Buccheri G, Ferrigno D, Tamburini M (1996) Karnofsky and ECOG Performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135

    Article  PubMed  CAS  Google Scholar 

  • Carbone DP, Mitsudomi T, Chiba I et al (1994) p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest 106 [Suppl6]:377S

    PubMed  CAS  Google Scholar 

  • Cattoretti G, Becker MH, Key G et al (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357

    Article  PubMed  CAS  Google Scholar 

  • Chen CY, Hsu CP, Hsu NY et al (2002) Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer. Oncol Rep 9:515

    PubMed  CAS  Google Scholar 

  • Chiba I, Takahashi T, Nau MM et al (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603

    PubMed  CAS  Google Scholar 

  • Cho JY, Kim JH, Lee YH et al (1997) Correlation between K-ras gene mutation and prognosis of patients with non-small cell lung carcinoma. Cancer 79:462

    Article  PubMed  CAS  Google Scholar 

  • Choma D, Daures JP, Quantin X et al (2001) Aneuploidy and prognosis of non-small cell lung cancer: a meta-analysis of published data. Br J Cancer 85:14

    Article  PubMed  CAS  Google Scholar 

  • Cote RJ, Beattie EJ, Chaiwun B et al (1995) Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 222:415

    PubMed  CAS  Google Scholar 

  • D’Amico TA, Massey M, Herndon JE 2nd et al (1999) A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117:736

    Article  PubMed  Google Scholar 

  • Deslaurier J, Brisson J, Cartier R et al (1989) Carcinoma of the lung. Evaluation of satellite nodules as a factor in influencing prognosis after resection. J Thorac Cardiovasc Surg 97:504

    Google Scholar 

  • Dhital K, Saunders CA, Seed PT et al (2000) [(l8)F] Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 18:425

    Article  PubMed  CAS  Google Scholar 

  • Dresler CN, Ritter JH, Wick MR et al (1995) Immunostains for blood group antigens lack prognostic significance in T1 lung carcinomas. Ann Thorac Surg 59:1069

    Article  PubMed  CAS  Google Scholar 

  • Duarte I, Buflin BL, Pennington MF et al (1998) Angiogenesis as a predictor of survival after surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 115:652

    Article  PubMed  CAS  Google Scholar 

  • Duhaylungsod FG, Lowe VJ, Patz EF et al (1995) Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 60:1348

    Article  Google Scholar 

  • Ebina M, Steinberg SM, Mulshine JL et al (1994) Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res 54:2496

    PubMed  CAS  Google Scholar 

  • Feinstein AR (1964) Symptomatic patterns, biologic behavior and prognosis in cancer of the lung. Ann Intern Med 61:27

    PubMed  CAS  Google Scholar 

  • Feld R, Abratt R, Graziano S et al (1997) Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer 17 [Suppl 1]:S3

    Article  PubMed  Google Scholar 

  • Feld R, Borges M, Giner V et al (1994) Prognostic factors in non-small cell lung cancer. Lung Cancer 11 [Suppl 3]:S19

    Article  PubMed  Google Scholar 

  • Ferguson MK, Skosey C, Hoffman PC et al (1990) Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol 8:1402

    PubMed  CAS  Google Scholar 

  • Finkelstein DM, Ettinger DS, Ruckdeschel JC (1986) Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol 4:702

    PubMed  CAS  Google Scholar 

  • Fontanini G, DeLaurentiis M, Vignati S et al (1998) Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small cell lung cancer:amphiregulin and microvessel count are independent indicators of survival. Clin Cancer Res 4:241

    PubMed  CAS  Google Scholar 

  • Fontanini G, Lucchi M, Vignati S et al (1997) Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 89:881

    Article  PubMed  CAS  Google Scholar 

  • Fontanini G, Vignati S, Bigini JD et al (1995) BCL-2 protein: a prognostic factor inversely correlated to p53 in non-small cell lung cancer. Br J Cancer 71:1003

    Article  PubMed  CAS  Google Scholar 

  • Fujii M, Motoi M, Saeki H et al (1993) Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer. Acta Med Okayama 47:103

    PubMed  CAS  Google Scholar 

  • Gaffney EF, O’Neil AJ, Staunton MJ (1994) bcl-2 and prognosis in non-small-cell lung carcinoma. N Engl J Med 330:1757

    Article  PubMed  CAS  Google Scholar 

  • Gail M, Eagan RT, Feld R et al (1984) Prognostic factors in patients with resected stage I NSCLC: a report from the Lung Cancer Study Group. Cancer 54:1802

    Article  PubMed  CAS  Google Scholar 

  • Gerdes J, Lemke H, Baisch H et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710

    PubMed  CAS  Google Scholar 

  • Giatromanolaki A, Gorgiulis V, Chetty R et al (1996) C-ERB B-2 oncoprotein expression in operable non-small cell lung cancer. Anticancer Res 16:987

    PubMed  CAS  Google Scholar 

  • Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 60:615

    Article  CAS  Google Scholar 

  • Graziano SL (1997) Non-small cell lung cancer: clinical value of new biological predictors. Lung Cancer 17 [Suppl 1]:S37

    Article  PubMed  Google Scholar 

  • Graziano SL, Mazid R, Newman N et al (1989) The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. J Clin Oncol 7:1398

    PubMed  CAS  Google Scholar 

  • Graziano SL, Tatum AH, Newman NB et al (1994) The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 54:2908

    PubMed  CAS  Google Scholar 

  • Graziano SL, Gamble GP, Newman NB et al (1999) The prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small cell lung cancer. I Clin Oncol 17:668

    CAS  Google Scholar 

  • Greatens TM, Niehans GA, Rubins JB et al (1998) Do molecular markers predict survival in non-small cell lung cancer? Am J Respir Crit Care Med 157:1093

    Article  PubMed  CAS  Google Scholar 

  • Gwin JL, Klein-Szanto AJ, Zhang SY et al (1994) Loss of blood group antigen A in non-small cell lung cancer. Ann Surg Oncol 1:423

    Article  PubMed  CAS  Google Scholar 

  • Harada M, Dosaka-Akita H, Miyamoto H et al (1992) Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer 69:72–77

    Article  PubMed  CAS  Google Scholar 

  • Harpole DH (1999) Commentary on “Prognostic markers in resected stage I and II non-small cell lung cancer patients”. Clin Lung Cancer 1:68

    Article  Google Scholar 

  • Harpole DH, Herndone JE, Young WG et al (l995a) Stage I non-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 76:787

    Article  Google Scholar 

  • Harpole DH, Herndon JE, Wolfe WG et al (l995b) A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology and oncoprotein expression. Cancer Res 55:51

    Google Scholar 

  • Harpole DH, Richards WG, Herndon JE et al (1996) Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 61:1470

    Article  PubMed  Google Scholar 

  • Higashi K, Veda y, Ayabe K et al (2000) FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun 21: 707

    Article  PubMed  CAS  Google Scholar 

  • Hommura F, Dosaka-Akita H, Mishina T et al (1999) Prognostic significance of p27KIPI protein and ki-67 growth fraction in non-small cell lung cancer. Lung Cancer 24:81

    Article  Google Scholar 

  • Hsu NY, Ho HC, Chow KC et al (2001) Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61:2727

    PubMed  CAS  Google Scholar 

  • Icard P, Regnard JF, Essomba A et al (1994) Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58:811

    Article  PubMed  CAS  Google Scholar 

  • Ichinose Y, Yano T, Asoh H et al (1995) Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 110:601

    Article  PubMed  CAS  Google Scholar 

  • Inoue T, Ishida T, Sugio K et al (1994) Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res 54:6133

    PubMed  CAS  Google Scholar 

  • Ishida T, Kaneko S, Akazawa K et al (1993) Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 53:5000

    PubMed  CAS  Google Scholar 

  • Isobe H, Miyamoto H, Shimizu T et al (1990) Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 65:1391

    Article  PubMed  CAS  Google Scholar 

  • Izbicki JR, Passlick, Hosch SB et al (1996) Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: significance of nodal micrometastasis. J Thorac Cardiovasc Surg 112:623

    Article  PubMed  CAS  Google Scholar 

  • Izumi M, Nakanishi Y, Yoshino I et al (2001) Expression of tumorassociated antigen RCASI correlates significantly with poor prognosis in non-small cell lung carcinoma. Cancer 92:446

    Article  PubMed  CAS  Google Scholar 

  • Jansen RL, Hupperets PS, Arends JW et al (1998) MIB-1 labeling index is an independent prognostic marker in primary breast cancer. Br J Cancer 78:460

    Article  PubMed  CAS  Google Scholar 

  • Jazieh AR, Hussain Mohammad, Howington JA et al (2000) Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 70:1168

    Article  PubMed  CAS  Google Scholar 

  • Kaneko S, Ishida T, Sugio K et al (1991) Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer. Cancer Res 51:4008

    PubMed  CAS  Google Scholar 

  • Kern JA, Schwartz DA, Nordberg JE et al (1990) p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50:5184–5187

    PubMed  CAS  Google Scholar 

  • Kessler R, Gasser B, Massard G et al (1996) Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 62:1489

    Article  PubMed  CAS  Google Scholar 

  • Kimura Y, Fujii T, Hamamoto K et al (1990) Serum CA 125 level is a good prognostic indicator in lung cancer. Br J Cancer 62:676

    Article  PubMed  CAS  Google Scholar 

  • Klatersky J, Sculier IP, Bureau G et al (1989) Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer. J Clin Oncol 7:1087

    Google Scholar 

  • Komaki R, Milas L, Ro JY et al (1998) Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 40:787

    Article  PubMed  CAS  Google Scholar 

  • Kos J, Sekirnik A, Kopitar G, Cimerman N et al (2001) Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br J Cancer 85:1193

    Article  PubMed  CAS  Google Scholar 

  • Kubuschok B, Passlick B, Izbicki JR et al (1999) Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 17:19

    PubMed  CAS  Google Scholar 

  • Kwiatkowski DJ Jr, DHH, Godleski J et al (1998) Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications. J Clin Oncol 16:2468

    PubMed  CAS  Google Scholar 

  • Lanzotti VJ, Thomas DR, Boyle LE et al (1977) Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria. Cancer 39:303

    Article  PubMed  CAS  Google Scholar 

  • Lee JS, Ro JY, Sahin AA et al (1991) Expression of blood-group antigen A: a favorable prognostic factor in non-small cell lung cancer. N Engl J Med 324:1084

    Article  PubMed  CAS  Google Scholar 

  • Linnoila RI, Jensen S, Steinberg S et al (1989) Neuroendocrine differentiation in non-small cell lung cancer correlates with favorable response to chemotherapy. Proc Am Soc 8:248

    Google Scholar 

  • Linnoila RI, Piantadosi S, Ruckdeschel JC (1994) Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. Chest 106:367S

    PubMed  CAS  Google Scholar 

  • Lipford EH III, Ehhleston JC, Lillemoe KD et al (1984) Prognostic factors in surgically resected limited stage non-small cell carcinoma of the lung. Am J Surg Pathol 8:357

    Article  PubMed  Google Scholar 

  • Little AG, Wu HS, Ferguson MK et al (1990) Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 160:630

    Article  PubMed  CAS  Google Scholar 

  • Luedke DW, Einhorn L, Omura GA et al (1990) Randomized comparison of two combination regimens versus minimal chemotherapy in non-small cell lung cancer: a Southeastern Cancer Study Group Trial. J Clin Oncol 8:886

    PubMed  CAS  Google Scholar 

  • Macchiarini P, Fontanini GM, Hardin MJ et al (1992) Relation of neovascul arization to metastasis of non-small cell lung cancer. Lancet 340:145

    Article  PubMed  CAS  Google Scholar 

  • Macchiarini P, Fontanini G, Hardin MJ et al (1993) Blood vessel invasion by tumor cells predicts recurrence in completely resected TlNOMO non-small cell lung cancer. J Thorac Cardiovase Surg 106:80

    CAS  Google Scholar 

  • Maggi G, Casadio C, Cianci R et al (1993) Results of surgical resection of stage IIIa (N2) non small cell lung cancer, according to the site of the mediastinal metastases. Int Surg 78:213

    PubMed  CAS  Google Scholar 

  • Mankoff DA, Shields AF, Graham MM et al (1998) Kinetic analysis of 2-[carbo-ll) thymidine PET imaging studies: compartmental model and mathematical analysis. J Nucl Med 39:1043

    PubMed  CAS  Google Scholar 

  • Martini N, Bains MS, Burt ME et al (1995) Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109:120

    Article  PubMed  CAS  Google Scholar 

  • Martini N, Burt M, Bains M et al (1992) Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 54:460

    Article  PubMed  CAS  Google Scholar 

  • Matsumoto H, Muramatsu H, Shimotakahara T et al (1993) Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas. Cancer 72:75

    Article  PubMed  CAS  Google Scholar 

  • McLaren R, Kuzu I, Dunnill M et al (1992) The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 66:735

    Article  PubMed  CAS  Google Scholar 

  • Mehdi SA, Tatum AH, Newman NB et al (1999) Prognostic markers in resected stage I and II non-small cell lung cancer: an analysiss of 260 patients with 5 year follow-up. Clin Lung Cancer 1:59

    Article  PubMed  CAS  Google Scholar 

  • Miller TP, Chen TT, Coltman Ca et al (1986) Effect of alternating combination chemotherapy on survival of ambulatory patient s with metastatic large cell and adenocarcinoma of the lung. A Southwest Oncology Group Study. J Clin Oncol 4:502

    PubMed  CAS  Google Scholar 

  • Mitsudomi T, Steiberg SM, Oie H et al (1991) Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 51:4999

    PubMed  CAS  Google Scholar 

  • Mitsudomi T, Steinberg SM, Nau MM et al (1992) p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171

    PubMed  CAS  Google Scholar 

  • Mitsudomi T, Hamajima N, Ogawa M et al (2000) Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 6:4055

    PubMed  CAS  Google Scholar 

  • Miyake M, Taki T, Hitomi S et al (1992) Correlation of expression of H/Ley/Leb antigens with survival in patients with carcinoma of the lung. N Engl J Med 327:14

    Article  PubMed  CAS  Google Scholar 

  • Mizushima Y, Noto H, Sugiyama S et al (1997) Survival after pneumonectomy for lung patients in the elderly. Ann Thorac Surg 64:93

    Article  Google Scholar 

  • Molino A, Micciolo R, Turazza M et al (1997) Ki-67 immunostaining in 322 primary breast cancers:associations with clinical and pathological variables and prognosis. Int J Cancer 74:433

    Article  PubMed  CAS  Google Scholar 

  • Mori M, Kohli A, Baker SP et al (1997) Laminin and cathepsin Bas a prognostic factor in stage I non-small cell lung cancer: are they useful? Modern Pathol 10:572

    CAS  Google Scholar 

  • Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710

    Article  PubMed  CAS  Google Scholar 

  • Murgueza JM, Diez M, Torres AJ et al (1997) Prognostic value of flow cytometric DNA analysis in non-small cell lung cancer: rationales of sequential processing of frozen and paraffin-embedded tissue. World J Surg 21:323

    Article  Google Scholar 

  • Nabeshima K, Shimao Y, Inoue T et al (2002) Matrix metalloproteinases (MMP) in lung cancer. Nippon Rinsho 60 [Suppl 5]: 103

    PubMed  Google Scholar 

  • Naito T, Satoh H, Ishikawa H et al (1997) Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 17:4743

    PubMed  CAS  Google Scholar 

  • Naruke T, Tsuchiya R, Kondo H et al (2001) Prognosis and survival for bronchogenic carcinoma based on the 1997 TNM staging classification: the Japanese experience. Ann Thorac Surg 71:1759

    Article  PubMed  CAS  Google Scholar 

  • O’Connell JP, Kris MG, Gralla RJ et al (1986) Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol 4:1604

    PubMed  Google Scholar 

  • Ohgami A, Tetsuya M, Kenji S et al (1997) Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer without overt meta stases. Lancet 64:363

    CAS  Google Scholar 

  • Ohsaki Y, Toyoshima E, Fujiuchi S et al (1996) p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin Cancer Res 2:915

    PubMed  CAS  Google Scholar 

  • Okada M, Tsubota N, Yoshimura M et al (1999) Evaluation of TNM classification for lung carcinoma with ipsilateral intrapulmonary metastasis. Ann Thorac Surg 68:326

    Article  PubMed  CAS  Google Scholar 

  • Oyama T, Mitsudomi T, Yoshida Y et al (1993) Nucleolar organizer regions are independently associated with a shortened survival in patients with non-small cell lung cancer. Surg Oncol 6:341

    Article  Google Scholar 

  • Padilla J, Calvo V, Penalver JC et al (1997) Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 63:324

    Article  PubMed  CAS  Google Scholar 

  • Paesmans M, Sculier JP, Libert P et al (1995) Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1502 patients. J Clin Oncol 13:1221

    PubMed  CAS  Google Scholar 

  • Pairolero PC, William DE, Bergstralh EJ et al (1984) Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 38:412

    Article  Google Scholar 

  • Palomares MR, Sayre JW, Shekar KC et al (1996) Gender influence on weight loss pattern and survival of non-small cell lung carcinoma patients. Cancer 78:2119

    Article  PubMed  CAS  Google Scholar 

  • Pantel K, Izbicki J, Passlick B et al (1996) Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649

    Article  PubMed  CAS  Google Scholar 

  • Pantel K, Passlick B, Vogt J et al (1998) Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small cell lung cancer. J Clin Oncol 16:1407

    PubMed  CAS  Google Scholar 

  • Passlick B, Izbicki JR, Kubuschok B (1994) Immunohistochemical assessment of individual tumor cells in the lymph nodes of patients with non-small cell lung cancer. J Clin Oncol 12:1827

    PubMed  CAS  Google Scholar 

  • Pastorino U, Andreola S, Tagliabue E et al (1977) Immunohistochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15:2858

    Google Scholar 

  • Pastorino U, Andreola S, Tagliabue E et al (1997) Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15:2858

    PubMed  CAS  Google Scholar 

  • Pastorino U, Valente M, Cataldo I (1986) Perioperative blood transfusion and prognosis of resected stage Ia lung cancer. Eur J Cancer Clin Oncol 22:1375

    Article  PubMed  CAS  Google Scholar 

  • Pelletier MP, Edwardes MD, Michel RP et al (2001) Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 44:180

    PubMed  CAS  Google Scholar 

  • Pena CM, Rice TW, Ahmad M et al (1992) Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest 102:84

    Article  PubMed  CAS  Google Scholar 

  • Pence JC, Kerns BM, Dodge RK et al (1993) Prognostic significance of the proliferation index in surgically resected non-small cell lung cancer. Arch Surg 128:1382

    Article  PubMed  CAS  Google Scholar 

  • Pezzella F, Turley H, Kuzu I et al (1993) Bcl-2 protein in non-small lung carcinoma. N Engl J Med 329:690

    Article  PubMed  CAS  Google Scholar 

  • Piantadosi S, Moores DW, McKneally MF (1994) The adverse effect of perioperative blood transfusion in lung cancer. Chest 106 [Suppl6]:382S

    Article  PubMed  CAS  Google Scholar 

  • Poncelet AJ, Weynand B, Ferdin F (2001) Bone marrow micrornetastas is might not be a short-term predictor of survival in early stages non-small cell lung carcinoma. Eur J Cardio Thorac Surg 20:481

    Article  CAS  Google Scholar 

  • Puglisi F, Aprile G, Bruckbauer M et al (2001) Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas. Cancer Lett 162:97

    Article  PubMed  CAS  Google Scholar 

  • Pugsley JM, Schmidt RA, Vesselle H et al (2002) The Ki-67 Index and Survival in non-small cell lung cancer: a review and relevance to positron emission tomography. Cancer J 8:222

    Article  PubMed  Google Scholar 

  • Quinlan DC, Davidson AG, Summers CL et al (1992) Accumulation of p53 protein correlation with a poor prognosis in human lung cancer. Cancer Res 52:4828

    PubMed  CAS  Google Scholar 

  • Rainio P, Bloigu R, Satta J et al (1996) Ten-year survival after resection for lung carcinoma. Effect of blood transfusion and tumour stage on outcome. Scand J Thorac Cardiovasc Surg 30:87

    Article  PubMed  CAS  Google Scholar 

  • Rapp E, Pater JL, Willan A et al (1988) Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer — report of a Canadian multicenter randomized trial. J Clin Onco1 6:633

    CAS  Google Scholar 

  • Read RC, Schaefer R, North N et al (1988) Diameter, cell type and survival in stage I primary non-small cell lung cancer. Arch Surg 123:446

    Article  PubMed  CAS  Google Scholar 

  • Read RC, Yoder G, Schaeffer RC (1990) Survival after conservative resection for T1 NO MO non-small cell lung cancer. Ann Thorae Surg 49:391

    Article  CAS  Google Scholar 

  • Rice TW, Tubbs RR, Hoeltge GA et al (1995) Expression of blood group ant igen A by stage I non-small cell lung carcinomas. Ann Thorac Surg 59:568

    Article  PubMed  CAS  Google Scholar 

  • Ries LA (1994) Influence of extent of disease, histology and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 10:21

    Article  PubMed  CAS  Google Scholar 

  • Riquet M, Manac′h D, Le Pimpec B (1997) Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter. Eur J Cardiothorac Surg 11:440

    Article  PubMed  CAS  Google Scholar 

  • Rodenhuis S, Slebos RJ (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res [Suppl] 52: 2665

    Google Scholar 

  • Rodenhuis S, Boerrigter L, Top B et al (1997) Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study. J Clin Onco1 15:285

    CAS  Google Scholar 

  • Rodrigues OR, Antonangelo L, Yagin et al (1997) Prognostic significance of argyrophilic nucleolar organizer region (AgNOR) in resected non-small cell lung cancer (NSCLC). Jpn J Clin Oncol 27:298

    Article  PubMed  CAS  Google Scholar 

  • Rorke S, Murphy S, Khalifa M et al (2001) Prognostic significance of BAG-I expression in non-small cell lung cancer. Int J Cancer 95:317

    Article  PubMed  CAS  Google Scholar 

  • Rosell R, Li S, Mate JL et al (1993) A prognostic impact of mutated k-ras gene in surgically resected non-small cell lung cancer patients. Oncogene 8:2407

    PubMed  CAS  Google Scholar 

  • Rubins JB, Dunitz J, Rubins HB et al (1998) Serum carcinoernbryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116:412

    Article  PubMed  CAS  Google Scholar 

  • Rusch VW, Dmitrovsky E (1995) Molecular biologic features of non-small cell lung cancer: clinical implications. Chest Surg Clin North Am 5:39

    CAS  Google Scholar 

  • Sahin AA, Ro JY, El-Naggar AK et al (1990) Flow cytometric analysis of the DNA content of non-small cell lung cancer. Cancer 65:530

    Article  PubMed  CAS  Google Scholar 

  • Salgia R, Skarin AT (1998) Molecular abnormalities in lung cancer. JCO 16:1207

    CAS  Google Scholar 

  • Schiller JH, Adak S, Feins R et al (1999) Prognostic significance of p53 and K-ras mutations in primary resected non-small cell lung cancer:preliminary results from a prospective randomized trial of postoperative adjuvant therapy (Intergroup Trial 0115). Proc Am Soc Clin Oncol 18:464a (abstract 1789)

    Google Scholar 

  • Segawa Y, Okahara M et al (1996) Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 15:67

    Article  PubMed  Google Scholar 

  • Shiba M, Kohno H, Kakizawa K et al (2000) Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected non-small cell lung carcinoma. Cancer 89:1457

    Article  PubMed  CAS  Google Scholar 

  • Shields AF, Grierson JR, Dohmen BM et al (1998) Imaging proliferat ion in vivo with [F-18] FLT and positron emission tomography. Nat Med 4:1334

    Article  PubMed  CAS  Google Scholar 

  • Shields TW (1983) Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung. Surg Gynecol Obstet 157:185

    PubMed  CAS  Google Scholar 

  • Slebos RJ, Kibbelaar RE, Dalesio O et al (1990) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561

    Article  PubMed  CAS  Google Scholar 

  • Sorensen JB (1994) Impact of prognostics factors on endpoints for clinical studies. Lung Cancer 11 [Suppl 3]:S45

    Article  PubMed  Google Scholar 

  • Stanley KE (1980) Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65:25

    PubMed  CAS  Google Scholar 

  • Staruss GM (1997) Prognostic markers in respectable non-small cell lung cancer. Hematol/Oncol Clin North Am 1:409

    Article  Google Scholar 

  • Stevenson H, Gazdar AF, Phelps R (1990) Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small cell lung cancer. Ann Intern Med 113:764

    PubMed  CAS  Google Scholar 

  • Sugio K, Ishida T, Yokoyama H et al (1992) Ras gene mutations as a prognostic marker in adenocarcinoma of the lung without lymph node metastasis. Cancer Res 52:2903

    PubMed  CAS  Google Scholar 

  • Sugio K, Tsukamoto S, Ushijima C et al (2001) Clinical significance of the Rb expression in adenocarcinoma of the lung. Anticancer Res 21:1931

    PubMed  CAS  Google Scholar 

  • Sukoh N, Abe S, Ogura S et al (1994) Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer 74:46

    Article  PubMed  CAS  Google Scholar 

  • Sulzer MA, Leers MPG, Noord JAV et al (1998) Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavourable prognosis in non-small cell lung cancer. Am J Crit Care Med 157:1319

    Article  CAS  Google Scholar 

  • Suzuki K, Nagai K, Yoshida J et al (1999) Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 67:927

    Article  PubMed  CAS  Google Scholar 

  • Takise A, Kodama T, Shimosata Y et al (1988) Histopathologic prognostic factors in adenocarcinoma of the peripheral lung less than 2 em in diameter. Cancer 61:2083

    Article  PubMed  CAS  Google Scholar 

  • Tanaka F, Miyahara R, Ohtake Y et al (1998) Lewis Y antigen expression and postoperative survival in non-small cell lung cancer. Ann Thorac Surg 157:1093

    Google Scholar 

  • Tartter PI, Burrows L, Kirschner P (1984) Perioperative blood transfusion adversely affects prognosis after resection of Stage I (subset NO) non-oat cell lung cancer. J Thorac Cardiovase Surg 88:659

    CAS  Google Scholar 

  • Tateishi M, Ishida T, Mitsudomi T et al (1991) Prognostic value of c-erbB-2 protein overexpression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27:1372

    Article  PubMed  CAS  Google Scholar 

  • TenVelde GP, Havenith MG, Volovics A et al (1991) Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 67:3001

    Article  CAS  Google Scholar 

  • Thomas P, Doddoli C, Thirion X et al (2002) Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection. Ann Thorac Surg 73:1065

    Article  PubMed  Google Scholar 

  • Thomas PA, Piantadosi S (1987) Postoperative T1N0 non-small cell lung cancer: squamous versus nonsquamous recurrences. J Thorac Cardiovasc Surg 94:349

    Google Scholar 

  • Tisi E, Lissoni P, Angeli M et al (1992) Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer 69:2458

    Article  PubMed  CAS  Google Scholar 

  • Unger JM, Coltman CA, Appelbaum FR et al (2003) African Americans have worse survival in hormone-related cancers. A Southwest Oncology Group Study. Proc Amer Soc Clin Oncol 22:529

    Google Scholar 

  • Uramoto H, Osaki T, Inoue M et al (1999) Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients. Eur J Cancer 35:1462

    Article  PubMed  CAS  Google Scholar 

  • Van Klaveren RJ, Festen J, Otten HJ et al (1993) Prognosis of unsuspected but completely resected N2 non-small cell lung cancer. Ann Thorac Surg 56:300

    Article  PubMed  Google Scholar 

  • Van Velzen E, Snijder RJ, Brutel de la Rivieire A et al (1997) Lymph node type as a prognostic factor for survival in T2 Nl M0 non-small cell lung carcinoma. Ann Thorac Surg 63:1436

    Article  PubMed  Google Scholar 

  • Vander Borght T, Pauwels S, Lambotte L et al (1994) Brain tumor imaging with PET and 2-[carbon-11] thymidine. J Nuel Med 35:974

    Google Scholar 

  • Vansteenkiste J, Stroobants SG, Dupont PJ et al (1999) Prognostic importance of standardized uptake value on (18) F-fluoro-2-deoxyglucose-positron emission tomography scan in non-small cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 17:3201

    PubMed  CAS  Google Scholar 

  • Vesselle H, Schmidt RA, Pugsley JM et al (2000) Lung cancer proliferation correlates with [F-18] fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837

    PubMed  CAS  Google Scholar 

  • Volm M, Koomagi R (2000) Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer. Oncol Rep 7:95

    PubMed  CAS  Google Scholar 

  • Volm M, Hahn EW, Mattern J et al (1988) Five-year follow-up study of independent elinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 48:2923

    PubMed  CAS  Google Scholar 

  • Volm M, Rittgen W, Drings P (1998) Prognostic value of ERBB-1, VEGF, cyelin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 77:663

    Article  PubMed  CAS  Google Scholar 

  • Wang Z, Zhao X (1998) Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes. Zhonghua Jie He He Hu Xi Za Zhi 21:164

    PubMed  CAS  Google Scholar 

  • Werle B, Kraft C, Lah TT et al (2000) Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with non-small cell lung carcinoma. Cancer 89:2282

    Article  PubMed  CAS  Google Scholar 

  • Wertzel H, Siebert H, LangeW et al (1998) Results after surgery in stage I bronchogenic carcinoma. Thorac Cardiovasc Surg 46:365

    Article  PubMed  CAS  Google Scholar 

  • Xu HJ, Quinlan DC, Davidson AG et al (1994) Altered retinoblastoma protein expression and prognosis in early stage non-small cell lung carcinoma. J Natl Cancer Inst 86:695

    Article  PubMed  CAS  Google Scholar 

  • Yano T, Yokoyama H, Inoue T et al (1994) Surgical results and prognostic factors of pathologic N1 disease in non-small cell carcinoma of the lung. Significance of Nl level: Lobar or hilar nodes. J Thorac Cardiovasc Surg 107:1398

    PubMed  CAS  Google Scholar 

  • Ylisirnio S, Hoyhtya M, Makitaro R et al (2001) Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res 7:1633

    PubMed  CAS  Google Scholar 

  • Yu C, Shun C, Yang P et al (1997) Sialomucin expression is associated with erb B-2 oncoprotein overexpression, early recurrence, and cancer death in non-small cell lung cancer. Am J Respir Crit Care Med 155:1419

    Article  PubMed  CAS  Google Scholar 

  • Zelen M (1973) Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 4:21

    Google Scholar 

  • Zimmerman PV, Bint MH, Hawson GAT et al (1987) Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 2:530

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. I. Quejada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. S. Albain
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Médicine, Institut Jules Bordet, 1, rue Héger-Bordet, 1000, Bruxelles, Belgium

    Jean-Paul Sculier M.D., Ph.D.

  2. 1111 Sunset Road, Winnetka, IL, 60093, USA

    Willard A. Fry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Quejada, M.I., Albain, K.S. (2004). Prognostic Factors in Non-Small Cell Lung Cancer. In: Sculier, JP., Fry, W.A. (eds) Malignant Tumors of the Lung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18698-1_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18698-1_37

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62253-3

  • Online ISBN: 978-3-642-18698-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation